MPH

MEREO BIOPHARMA GROUP PLC ORD GBP0.003 (REG S)

TitleTime
Annual General MeetingFri 22/05/20 | 12:00
Holding(s) in CompanyThu 21/05/20 | 16:18
Business Update and Directorate ChangeFri 27/03/20 | 12:00
Block listing Interim ReviewFri 06/03/20 | 07:00
Positive feedback from phase 2 meeting with FDAFri 28/02/20 | 12:00
Holding(s) in CompanyTue 25/02/20 | 15:00
Holding(s) in CompanyFri 21/02/20 | 14:31
Holding(s) in CompanyFri 21/02/20 | 14:30
Second Price Monitoring ExtnThu 20/02/20 | 16:41
Price Monitoring ExtensionThu 20/02/20 | 16:36
Director and other PDMR DealingsThu 20/02/20 | 16:06
Equity InvestmentWed 19/02/20 | 08:00
Price Monitoring ExtensionTue 18/02/20 | 11:00
Holding(s) in CompanyThu 13/02/20 | 10:45
Holding(s) in CompanyWed 12/02/20 | 16:00
Update on DistributionWed 12/02/20 | 13:00
Holding(s) in CompanyTue 11/02/20 | 15:00
Second Price Monitoring ExtnMon 10/02/20 | 14:06
Price Monitoring ExtensionMon 10/02/20 | 14:00
Novartis Financing; Purchase Agreement with AspireMon 10/02/20 | 12:00
Second Price Monitoring ExtnTue 28/01/20 | 14:05
Price Monitoring ExtensionTue 28/01/20 | 14:00
Additional positive data from phase 2b studyTue 14/01/20 | 12:00
Second Price Monitoring ExtnMon 13/01/20 | 16:41
Price Monitoring ExtensionMon 13/01/20 | 16:35
Mereo and Oncologie Global Licensing AgreementMon 13/01/20 | 12:00
Holding(s) in CompanyMon 06/01/20 | 16:45
Second Price Monitoring ExtnThu 02/01/20 | 11:05
Price Monitoring ExtensionThu 02/01/20 | 11:00
Price Monitoring ExtensionTue 31/12/19 | 11:00
Second Price Monitoring ExtnFri 27/12/19 | 11:05
Price Monitoring ExtensionFri 27/12/19 | 11:00
Notification of Major Holdings in CompanyWed 18/12/19 | 14:22
Notification of Holdings in CompanyMon 16/12/19 | 14:17
PDMR ShareholdingTue 03/12/19 | 16:54
Director ShareholdingWed 27/11/19 | 16:12
Director ShareholdingMon 25/11/19 | 17:02
Director/PDMR ShareholdingFri 22/11/19 | 17:09
PDMR ShareholdingWed 20/11/19 | 14:31
Second Price Monitoring ExtnMon 11/11/19 | 11:05
Price Monitoring ExtensionMon 11/11/19 | 11:00
Mereo BioPharma Phase 2b ASTEROID StudyMon 11/11/19 | 07:00
Holdings in CompanyFri 18/10/19 | 07:00
Holdings in CompanyThu 17/10/19 | 14:20
Notification of Director DealingMon 14/10/19 | 12:21
FDA Fast Track Designation for NavicixizumabMon 07/10/19 | 13:00
PDMR NotificationFri 04/10/19 | 14:57
PDMR NotificationWed 02/10/19 | 15:54
PDMR DealingThu 26/09/19 | 12:04
PDMR DealingWed 25/09/19 | 10:38
Director DealingTue 24/09/19 | 13:00
Director ShareholdingFri 20/09/19 | 14:22
Interim results for 6 months ended June 30, 2019Tue 17/09/19 | 07:00
Directors' details updateFri 13/09/19 | 15:30
Notice of ResultsTue 10/09/19 | 13:00
Block listing Interim ReviewFri 06/09/19 | 07:00
Director/PDMR ShareholdingFri 16/08/19 | 13:51
PDMR ShareholdingThu 15/08/19 | 16:59
Second Price Monitoring ExtnMon 12/08/19 | 16:41
Price Monitoring ExtensionMon 12/08/19 | 16:35
Price Monitoring ExtensionFri 09/08/19 | 16:35
Director DeclarationWed 31/07/19 | 12:51
PDMR ShareholdingThu 25/07/19 | 16:56
Director/PDMR ShareholdingWed 24/07/19 | 10:08
Director/PDMR ShareholdingFri 19/07/19 | 13:21
Successful Type B Meeting with U.S. FDAMon 15/07/19 | 13:00
Holding(s) in CompanyMon 08/07/19 | 15:54
Second Price Monitoring ExtnWed 03/07/19 | 16:41
Price Monitoring ExtensionWed 03/07/19 | 16:35
Holding(s) in CompanyThu 27/06/19 | 15:33
Holding(s) in CompanyWed 26/06/19 | 16:36
Conversion of loan note and issue of equityFri 21/06/19 | 13:00
Result of AGMThu 20/06/19 | 07:00
Update on Etigilimab (TIGIT) PartnershipThu 13/06/19 | 13:00
Positive early 6 month dataThu 30/05/19 | 07:00
Director/PDMR ShareholdingThu 23/05/19 | 16:11
PDMR ShareholdingWed 22/05/19 | 09:45
Director/PDMR ShareholdingTue 21/05/19 | 15:08
Notice of AGMMon 20/05/19 | 07:00
Director/PDMR ShareholdingWed 08/05/19 | 13:53
Re-release: Intention to Purchase SharesTue 07/05/19 | 07:00
Issue of WarrantsTue 07/05/19 | 07:00
Intention to Purchase Shares by Trustee of EBTFri 03/05/19 | 17:00
Director/PDMR ShareholdingFri 03/05/19 | 14:02
Director/PDMR ShareholdingWed 01/05/19 | 15:47
Director/PDMR ShareholdingTue 30/04/19 | 15:15
Director/PDMR ShareholdingTue 30/04/19 | 07:00
Publication of Annual Report and AccountsTue 30/04/19 | 07:00
Prelims Results for year ended December 31 2018Mon 29/04/19 | 07:00
Director/PDMR ShareholdingFri 26/04/19 | 15:01
Holding(s) in CompanyThu 25/04/19 | 15:36
Holding(s) in CompanyThu 25/04/19 | 15:29
Second Price Monitoring ExtnThu 25/04/19 | 11:05
Price Monitoring ExtensionThu 25/04/19 | 11:00
Admission to TradingWed 24/04/19 | 14:30
Completion of MergerTue 23/04/19 | 14:25
Merger UpdateThu 18/04/19 | 07:00
Successful end of Phase 2 Meeting with FDAMon 15/04/19 | 07:00
Publication of Form F-4Thu 21/03/19 | 07:00
Update on Proposed Combination of Mereo & OncoMedFri 15/03/19 | 11:45
Mereo CEO appointed NED of Elanco Animal HealthWed 13/03/19 | 11:00
Block Listing Interim ReviewWed 06/03/19 | 07:00
Update on Proposed Transaction with OncoMedFri 22/02/19 | 13:50
Board ChangeMon 11/02/19 | 07:00
Publication of F-4Fri 25/01/19 | 11:10
New Deferred Bonus PlanFri 18/01/19 | 07:00
BGS-649 Phase 2b data to be Presented at ENDO 2019Tue 15/01/19 | 07:00
Director/PDMR ShareholdingThu 27/12/18 | 10:02
Director/PDMR ShareholdingMon 24/12/18 | 07:00
Positive results from safety extension studyTue 18/12/18 | 07:00
Positive results from safety extension studyMon 17/12/18 | 18:25
AIM Rule 17 Disclosure StatementMon 17/12/18 | 15:44
Proposed combination of Mereo and OncoMedWed 05/12/18 | 13:09
Issue of WarrantsMon 26/11/18 | 07:00
First patient dosed in Phase 2 studyMon 05/11/18 | 07:00
Total Voting RightsWed 31/10/18 | 15:37
Completion of Patient Enrolment in Phase 2b studyMon 15/10/18 | 07:00
Revised Credit Facility and Issue of WarrantsMon 01/10/18 | 10:00
Block Listing ApplicationMon 03/09/18 | 07:00
Correction to Issued Share CapitalFri 31/08/18 | 18:25
Mereo BioPharma Interim Results 2018Wed 08/08/18 | 07:00
Exercise of OptionsMon 23/07/18 | 07:00
Notice of Interim ResultsMon 23/07/18 | 07:00
Result of Annual General MeetingThu 21/06/18 | 12:52
Successful Completion of PrimaryBid OfferTue 29/05/18 | 07:00
PrimaryBid.com OfferFri 25/05/18 | 16:31
Notice of AGMTue 22/05/18 | 07:00
Grant of OptionsFri 27/04/18 | 07:00
Update on Offering & Application to List on NasdaqThu 26/04/18 | 07:00
Offering and Application to List on NasdaqMon 09/04/18 | 11:34
Result of General MeetingFri 06/04/18 | 13:03
Publication of Annual ReportTue 03/04/18 | 07:00
Mereo BioPharma Files for Proposed Global OfferingMon 26/03/18 | 07:00
Final ResultsFri 23/03/18 | 07:00
PUBLICATION OF NOTICE OF GENERAL MEETINGTue 20/03/18 | 07:00
Mereo: Positive Top-Line Results for BGS-649Mon 19/03/18 | 07:00
Mereo BioPharma Appoints Wills Hughes-WilsonMon 26/02/18 | 07:00
£10m credit facility drawdown & issue of warrantsTue 02/01/18 | 07:00
Mereo Plans to Conduct Registered IPO in the USMon 18/12/17 | 07:00
Mereo BioPharma: Business UpdateWed 13/12/17 | 07:00
Positive results from Phase 2 trial with BCT-197Mon 11/12/17 | 07:00
BPS-804 receives PRIME designationMon 13/11/17 | 07:00
Holding(s) in CompanyMon 06/11/17 | 12:19
Mereo announces agreement with AstraZenecaMon 30/10/17 | 07:00
Update on BGS-649 Phase 2b StudyTue 05/09/17 | 07:00
Issue of WarrantsTue 22/08/17 | 09:17
Interim ResultsTue 08/08/17 | 07:12
Notice of ResultsMon 03/07/17 | 07:00
Result of AGMTue 27/06/17 | 11:23